AI Failures in Healthcare: Causes and Consequences

AI systems in healthcare fail more often and more consequentially than most patients realize. These failures span a wide range, from diagnostic algorithms that miss disease in certain skin tones to sepsis-prediction tools that generate thousands of false alarms while overlooking the majority of actual cases. The causes are not mysterious: they trace to how models are trained, what data they learn from, how clinicians interact with their outputs, and how little regulatory infrastructure exists to catch problems after a tool is deployed. Understanding these failures matters because AI adoption in medicine is accelerating, and the gap between what these systems promise and what they deliver can directly affect who gets treated, how quickly, and how well.

When AI Learns the Wrong Lesson

One of the most insidious causes of AI failure in healthcare is something researchers call shortcut learning. Instead of identifying the actual signs of a disease, the model latches onto unrelated patterns in the training data that happen to correlate with the diagnosis. An AI model trained on chest X-rays, for example, might learn that the presence of a chest tube or a portable radiographic marker (features that indicate a patient is in an intensive care unit) predicts a worse outcome, rather than learning to read the lung tissue itself.1PubMed Central. “Shortcuts” Causing Bias in Radiology Artificial Intelligence: Causes, Evaluation, and Mitigation The model performs well during testing because ICU patients genuinely are sicker, but the relationship it learned is a coincidence of the dataset, not a medical insight.

This matters because shortcut learning is invisible during the usual validation process. The model’s accuracy numbers look fine as long as the test data contains the same spurious correlations the training data did. Once deployed in a setting where those correlations break down, performance collapses. Shortcut learning essentially means the model is solving a different problem than the one clinicians think it is solving, and no amount of accuracy on a benchmark dataset can fix that mismatch.2PubMed Central. Shortcut learning in medical AI hinders generalization: method for estimating AI model generalization without external data

Data That Shifts After Deployment

Even a well-built model can degrade after it goes live, because the data it encounters in the real world inevitably changes. A model trained at academic hospitals and deployed in community hospitals, or trained on one patient population and applied to another, faces what researchers call distribution shift. One study found that transferring a clinical AI model from community to academic hospitals reduced performance for patients 65 and older, and when the study looked at shifts involving specific lab markers like BNP and D-dimer, it found that respiratory disease predictions dropped substantially, with an area-under-the-curve decrease of about 0.12.3JAMA Network Open. Detecting and Remediating Harmful Data Shifts for the Responsible Deployment of Clinical AI Models

These shifts happen for reasons that are entirely predictable. Community hospitals may have higher nursing home admission rates. Urban and suburban hospitals serve different demographics. Equipment and lab assay calibrations vary between facilities. The model was never exposed to these variations during training, so it treats them as noise or misinterprets them entirely. A retrospective simulation study confirmed that such postmarket shifts are a persistent problem, occurring when algorithms developed on heterogeneous data end up deployed in settings where data acquisition quality differs or certain patient groups are overrepresented.4PubMed Central. Distribution shift detection for the postmarket surveillance of medical AI algorithms: a retrospective simulation study

The Sepsis Prediction Debacle

Perhaps the most widely discussed real-world AI failure in healthcare involves the Epic Sepsis Model, a proprietary prediction tool embedded in the electronic health record system used by hundreds of hospitals. When researchers at the University of Michigan independently validated it, the results were sobering. At the recommended alert threshold, the model caught only about a third of sepsis cases while generating alerts for roughly 18% of all hospitalized patients, creating a massive burden of false alarms. Two out of three patients who actually developed sepsis were missed entirely.5JAMA Internal Medicine. External Validation of a Widely Implemented Proprietary Sepsis Prediction Model in Hospitalized Patients

A separate validation study in county emergency departments found even worse sensitivity. Within a six-hour window for sepsis onset, the model identified fewer than 15% of cases while maintaining high specificity, meaning it was excellent at not flagging people who were fine but terrible at flagging people who were sick.6PubMed Central. External validation of the Epic sepsis predictive model in 2 county emergency departments The practical upshot: clinicians at hospitals across the country were being bombarded with alerts that mostly did not correspond to actual sepsis, while true sepsis cases slipped through. This combination of alert fatigue and false reassurance is arguably worse than having no prediction tool at all, because it erodes clinician attention and confidence simultaneously.

Racial and Demographic Bias

AI tools trained on data that underrepresents certain groups tend to perform worst for those same groups. In dermatology, this problem is stark. A study evaluating state-of-the-art AI dermatology models found substantial limitations on dark skin tones and uncommon diseases.7PubMed Central. Disparities in dermatology AI performance on a diverse, curated clinical image set A review of the broader literature confirmed the pattern: AI systems are consistently less accurate for darker skin tones, with one study reporting melanoma detection accuracy of 60% for lighter skin datasets compared to 53% for darker skin datasets.8PubMed Central. Exploring the Diagnostic Capability of Artificial Intelligence in Dermatology for Darker Skin Tones: A Narrative Review A seven-percentage-point gap in cancer detection might sound small in the abstract, but applied across millions of screenings it translates to a meaningful number of missed melanomas in patients who already face barriers to care.

The bias problem extends well beyond imaging. A landmark study published in Science examined a widely used algorithm that determined which patients received extra care for complex medical needs. The algorithm used healthcare spending as a proxy for illness severity, but because Black patients in the United States historically receive less healthcare spending for the same conditions, the algorithm systematically rated Black patients as healthier than equally sick white patients. The bias arose not from any explicitly racial variable but from the choice of a proxy that encoded decades of unequal access into its predictions.9PubMed. Dissecting racial bias in an algorithm used to manage the health of populations This kind of failure is especially dangerous because the system’s designers may not have intended any bias and may not even be aware of it. The algorithm appeared to work well by conventional accuracy metrics; the disparity only became visible when researchers examined outcomes by race.

Automation Bias and Clinician Overreliance

A common assumption is that human clinicians serve as a safety net: even if the AI gets it wrong, the doctor will catch the mistake. The evidence suggests this assumption is dangerously optimistic. In a trial of physicians who had received AI training, those exposed to flawed AI recommendations scored about 14 percentage points lower on diagnostic accuracy than those who received error-free recommendations. When researchers looked at whether physicians correctly identified the top-choice diagnosis, the gap widened to over 18 percentage points.10medRxiv. Automation Bias in Large Language Model Assisted Diagnostic Reasoning Among AI-Trained Physicians These were not naive users; they had been specifically trained on AI systems, and they still followed the AI’s wrong answer more often than they caught it.

A separate study found that clinicians were about ten times more likely to make a correct decision when the AI recommendation was correct, but their accuracy dropped sharply when the AI was wrong, a pattern consistent with overreliance rather than independent verification.11PubMed. Impact of AI recommendation correctness on diagnostic accuracy in clinical decision-making The implication is uncomfortable: AI does not merely assist human judgment; it can actively degrade it. When the AI is right, the combination works beautifully. When the AI is wrong, the physician often goes wrong with it.

Alert Fatigue and the Risk of Deskilling

The sepsis model is not the only system drowning clinicians in irrelevant alerts. Clinical decision support systems more broadly generate enormous volumes of medication alerts, many of which have little clinical relevance. Override rates for these alerts run as high as 96%, meaning clinicians dismiss nearly every warning they receive.12Oxford Academic. The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: a scoping review That override rate is a symptom, not a cause. When a system cries wolf hundreds of times a day, the rational response is to stop listening. The danger is that genuinely critical alerts get buried in the noise.

There is also growing concern about what happens to clinicians’ own skills over time. One study found that AI-supported training improved radiologists’ sensitivity by about 12% and reduced their reading time per case by about 18%, but the researchers flagged an unresolved concern: whether long-term reliance on AI could erode the ability to make independent diagnostic judgments.13PubMed Central. Artificial intelligence in medicine: a scoping review of the risk of deskilling and loss of expertise among physicians If a generation of clinicians learns to diagnose with an AI crutch, what happens when the system goes down, or when it encounters a case type it has never seen? The efficiency gains are real, but the long-term dependency risk has barely been studied.

The Messy Reality of Health Records

AI models in healthcare are only as good as the data they train on, and electronic health records are far messier than most people imagine. A key challenge is that missing data in health records does not simply mean gaps. Sometimes a missing entry means “this was never tested,” other times it means “the result was normal and nobody bothered to document it,” and in many cases it is genuinely unclear which interpretation is correct. A patient without a documented history of heart failure may truly be free of the condition, or the clinician may have simply not recorded it.14PubMed Central. Strategies for handling missing data in electronic health record derived data

This ambiguity creates a particular problem for underserved populations. Patients who have less access to healthcare, or who seek care less frequently, have sparser records. When researchers examined this pattern in an intensive care setting, they found that missing data had a greater negative impact on disease prediction model performance for groups that tend to have less access to healthcare.15Journal of Biomedical Informatics. Mining for equitable health: Assessing the impact of missing data in electronic health records The model performs worst for the patients who need it most, because their data is thinnest. Health records also lack standardization across institutions in the United States, mixing structured data with free-text notes, collected at irregular intervals and in different formats. An AI model trained at one hospital system may encounter completely different documentation patterns at another.

Adversarial Attacks on Medical Images

Beyond accidental failures, there is the deliberate kind. Adversarial attacks involve making subtle, often invisible modifications to medical images that cause AI systems to misclassify them. These manipulations are typically imperceptible to the human eye but exploit specific vulnerabilities in how deep learning models process images, and they could theoretically lead to inaccurate diagnoses based on manipulated data.16European Journal of Radiology. Adversarial attacks in radiology – A systematic review Research has shown that even single-pixel changes to medical images can cause misclassification, raising concerns about the robustness of AI tools used in clinical imaging.17PubMed Central. Adversarial Attacks on Medical Image Classification

The threat is not hypothetical from a technical standpoint. Researchers have demonstrated “universal adversarial perturbations,” essentially reusable attack patterns that can fool a deep learning model on the vast majority of inputs. In one study, these nearly imperceptible perturbations achieved over 80% success rates for both targeted and nontargeted attacks on medical image classifiers.18PubMed Central. Universal adversarial attacks on deep neural networks for medical image classification While real-world adversarial attacks on clinical systems have not been widely documented, the existence of these vulnerabilities means that any healthcare AI system processing images needs security safeguards that most current deployments lack.

When AI Invents Its Own Medical References

The rise of large language models like ChatGPT and their competitors has introduced a new category of AI failure in healthcare: fabricated citations. When researchers asked several popular models to generate references for neurocritical care topics, 55% of the 300 citations checked contained verifiable inaccuracies, and about 28% corresponded to publications that simply do not exist. The fabrication rate varied dramatically across models, with one model inventing nonexistent papers half the time.19PubMed Central. Hallucination Rate of Peer-Reviewed Citations Generated by Large Language Models in Neurocritical Care

This is a distinct failure mode from the others discussed here. A prediction model that misses sepsis is wrong about the world; a language model that fabricates citations is wrong about what has been published. The danger is that a clinician or researcher who trusts an AI-generated reference list could base clinical decisions on evidence that literally does not exist. Language models produce text that reads with confident authority, complete with plausible-sounding journal names, author lists, and DOIs. Checking each reference against a database takes time that busy clinicians rarely have, making fabricated citations a practical, not just theoretical, risk.

Regulatory Gaps and Liability Questions

The regulatory landscape has not kept up with the pace of AI deployment. One fundamental problem is that AI medical devices can drift after approval. Unlike a stainless-steel hip implant, whose properties are fixed at manufacture, an AI model’s real-world performance changes as the patient population and data environment evolve. There is currently no mechanism in the FDA’s adverse-event reporting system to capture these gradual performance declines, because they do not correspond to a single reportable adverse event.20npj Digital Medicine. A general framework for governing marketed AI/ML medical devices Self-learning models, which update themselves based on new data acquired during patient care, pose an even thornier challenge: the model that was approved is not the same model that is running six months later.

Voluntary adverse-event databases may not capture eventual diagnostic or prognostic errors associated with AI performance gaps, and researchers have called for dedicated automated mechanisms for postmarket surveillance, potentially through linkages to electronic health record systems.21PubMed Central. Benefit-Risk Reporting for FDA-Cleared Artificial Intelligence−Enabled Medical Devices On the liability side, a systematic review found that the regulatory framework governing who is responsible when AI causes a diagnostic error is inadequate. There is no single regulation assigning liability across the AI supply chain, from the developer to the hospital to the clinician who acts on the output.22PubMed Central. Defining medical liability when artificial intelligence is applied on diagnostic algorithms: a systematic review If a model misses a cancer and the patient suffers, it remains genuinely unclear in most jurisdictions whether the software developer, the hospital that purchased it, or the physician who relied on it bears legal responsibility.

What Patients Want to Know

Patients are not passive bystanders in this story, and their expectations around AI differ from what healthcare systems typically assume. A study examining patient perspectives on informed consent found that people placed significantly more importance on receiving information when AI was involved in their diagnosis compared to when a human radiologist was consulted. Patients wanted to know whether an AI tool had been used, whether it agreed with the physician, and whether they could opt out. Gender, age, and income all influenced how much importance people placed on each of these topics.23PubMed Central. Patient perspectives on informed consent for medical AI: A web-based experiment

This suggests that transparency around AI use is not just a nice-to-have; patients actively want it. Yet most healthcare AI tools today are embedded in clinical workflows without any patient-facing disclosure. You may have already been triaged, screened, or risk-scored by an AI system without knowing it. A systematic review of AI-based triage in emergency departments found that while these systems can improve efficiency, they come with undertriage risks and variable accuracy, and the evidence base is dominated by single-center studies that may not generalize.24PubMed Central. Clinical Impact of Artificial Intelligence-Based Triage Systems in Emergency Departments: A Systematic Review Patients being sorted by these tools generally have no idea it is happening, no way to evaluate whether the tool has been validated for their specific demographic, and no obvious mechanism to flag concerns if they feel something was missed.

The Compounding Problem

What makes AI failures in healthcare especially concerning is how many of these issues interact. A model built on biased data gets deployed in a setting it was not trained for, where it faces distribution shift that further degrades performance. Clinicians, conditioned to trust the tool’s output, override their own instincts because of automation bias. Alert fatigue from excessive false alarms dulls their vigilance for the true positives that do come through. Missing and inconsistent health records mean that the very patients most likely to be harmed by these failures are also the hardest for the system to see clearly. And the regulatory framework that should catch all of this is still being built, often years behind the technology it is supposed to govern.

Each individual failure mode has a known set of mitigations: better training data, regular performance audits, external validation studies, adversarial robustness testing, human-factors research, clear liability frameworks. The challenge is that these mitigations require sustained effort, institutional will, and often money, while the incentive structure in healthcare AI favors speed to market and broad deployment. The gap between what is technically possible in terms of safe AI and what is actually practiced in clinical settings remains wide, and patients are the ones who bear the consequences of that gap.